Variant report
Variant | nsv1022186 |
---|---|
Chromosome Location | chr5:104252181-104283217 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:104256936..104259316-chr5:104275958..104278631,2 | K562 | blood: | |
2 | chr5:104277822..104279427-chr5:104300449..104302157,2 | MCF-7 | breast: | |
3 | chr5:104271936..104274851-chr5:104276428..104278480,3 | MCF-7 | breast: | |
4 | chr5:104245189..104247786-chr5:104277262..104279951,2 | MCF-7 | breast: | |
5 | chr5:104270441..104272983-chr5:104273696..104275223,2 | K562 | blood: | |
6 | chr5:104271936..104274851-chr5:104276428..104278480,3 | MCF-7 | breast: | |
7 | chr5:104246978..104249905-chr5:104251799..104254646,2 | MCF-7 | breast: | |
8 | chr5:104248370..104250240-chr5:104261197..104262793,2 | MCF-7 | breast: | |
9 | chr5:104270441..104272983-chr5:104273696..104275223,2 | K562 | blood: | |
10 | chr5:104256936..104259316-chr5:104275958..104278631,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NUDT12-7 | chr5:104253193-104253599 | ENSG00000253584 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251574 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191105202 | chr5:104253237-104253238 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs562145617 | chr5:104253261-104253262 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs556145974 | chr5:104253271-104253272 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs73208355 | chr5:104253272-104253273 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs149318578 | chr5:104253289-104253290 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs547507327 | chr5:104253330-104253331 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs74319256 | chr5:104253408-104253409 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs532178996 | chr5:104253433-104253434 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs183588085 | chr5:104253448-104253449 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs568950350 | chr5:104253449-104253450 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs538175909 | chr5:104253457-104253458 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs548168547 | chr5:104253474-104253475 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs568086811 | chr5:104253480-104253481 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs144643786 | chr5:104253495-104253496 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs373848517 | chr5:104253530-104253531 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs563286083 | chr5:104255802-104255803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529015036 | chr5:104255874-104255875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191679076 | chr5:104255879-104255880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76620084 | chr5:104256041-104256042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182902684 | chr5:104256051-104256052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551669349 | chr5:104256117-104256118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187507072 | chr5:104256135-104256136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537749638 | chr5:104256144-104256145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146440785 | chr5:104256178-104256179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139871644 | chr5:104256193-104256194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574717462 | chr5:104260008-104260009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572086117 | chr5:104260079-104260080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs423646 | chr5:104260108-104260109 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs188022334 | chr5:104260143-104260144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191730554 | chr5:104260150-104260151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545725163 | chr5:104260152-104260153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184279810 | chr5:104260163-104260164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374445410 | chr5:104260209-104260210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188962952 | chr5:104260257-104260258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368543224 | chr5:104260258-104260259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568082694 | chr5:104260287-104260288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192220998 | chr5:104260323-104260324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs185537556 | chr5:104260360-104260361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147734462 | chr5:104260409-104260410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73208363 | chr5:104260413-104260414 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs116718575 | chr5:104260481-104260482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543449629 | chr5:104260485-104260486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373899716 | chr5:104260567-104260568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530592926 | chr5:104260568-104260569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190408795 | chr5:104260569-104260570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71226922 | chr5:104260575-104260576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs57093065 | chr5:104260582-104260583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569900103 | chr5:104260609-104260610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs535774812 | chr5:104260703-104260704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564862748 | chr5:104260707-104260708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Obesity | 20622171 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:104255800-104256200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr5:104260000-104260800 | Enhancers | Fetal Intestine Large | intestine |
3 | chr5:104264600-104265200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr5:104265200-104268200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:104268200-104268400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr5:104268200-104268400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr5:104268400-104268600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr5:104277200-104277400 | Enhancers | Fetal Intestine Large | intestine |
9 | chr5:104277200-104277400 | Enhancers | Fetal Intestine Small | intestine |
10 | chr5:104277400-104278400 | Weak transcription | Fetal Intestine Large | intestine |
11 | chr5:104277600-104283000 | Weak transcription | Fetal Intestine Small | intestine |
12 | chr5:104277800-104278600 | Enhancers | Hela-S3 | cervix |
13 | chr5:104278200-104278800 | Enhancers | Colon Smooth Muscle | Colon |
14 | chr5:104278400-104279200 | Enhancers | Fetal Intestine Large | intestine |
15 | chr5:104279200-104283000 | Weak transcription | Fetal Intestine Large | intestine |
16 | chr5:104283000-104283800 | Enhancers | Fetal Intestine Large | intestine |
17 | chr5:104283000-104283800 | Enhancers | Fetal Intestine Small | intestine |